Andrew R. Berneshawi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Andrew R. Berneshawi has a total of 85 co-authors. Here are the top co-authors by number of shared publications:
- Alexander Ploss
Department of Molecular Biology, Princeton University
5 shared publications - Nicholas A. Crossland
National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA 02118, USA
4 shared publications Hans P. Gertje
National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA, USA
3 shared publications- Thomas R. Cafiero
Department of Molecular Biology, Princeton University, Princeton, NJ, USA
3 shared publications - Alejandro Benjamin Balazs
Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA
2 shared publications Amira Sheikh
Department of Microbiology, Boston University School of Medicine, Boston, MA, USA; National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA, USA
2 shared publications
Latest Publications
- Open Access
Liver-specific Mettl14 deletion induces nuclear heterotypia and dysregulates RNA export machinery
Modification of RNA with N 6 -methyladenosine (m 6 A) has gained attention in recent years as a general mechanism of gene regulation. In the liver, m 6 A, along with its associated machinery, has been studied as a potential biomarker of disease and cancer, with impacts on metabolism, cell cycle regulation, and pro-cancer state signaling. However these observational data have yet to be causally examined in vivo. For example, neither perturbation of the key m 6 A writers Mettl3 and Mettl14 , nor the m 6 A readers Ythdf1 and Ythdf2 have been thoroughly mechanistically characterized in vivo as they have been in vitro . To understand the functions of these machineries, we developed mouse models and found that deleting Mettl14 led to progressive liver injury characterized by nuclear heterotypia, with changes in mRNA splicing, processing and export leading to increases in mRNA surveillance and recycling.
Open AccessLiver-specific Mettl14 deletion induces nuclear heterotypia and dysregulates RNA export machinery
Modification of RNA with N 6 -methyladenosine (m 6 A) has gained attention in recent years as a general mechanism of gene regulation. In the liver, m 6 A, along with its associated machinery, has been studied as a potential biomarker of disease and cancer, with impacts on metabolism, cell cycle regulation, and pro-cancer state signaling. However these observational data have yet to be causally examined in vivo. For example, neither perturbation of the key m 6 A writers Mettl3 and Mettl14 , nor the m 6 A readers Ythdf1 and Ythdf2 have been thoroughly mechanistically characterized in vivo as they have been in vitro . To understand the functions of these machineries, we developed mouse models and found that deleting Mettl14 led to progressive liver injury characterized by nuclear heterotypia, with changes in mRNA splicing, processing and export leading to increases in mRNA surveillance and recycling.
- Open Access
- 9 July 2022
- Published by Elsevier in JHEP Reports
- Vol. 4 (9) , 100534
Conversion of hepatitis B virus relaxed circular to covalently closed circular DNA is supported in murine cells
- 9 July 2022
- Published by Elsevier in JHEP Reports
- Vol. 4 (9) , 100534
Open AccessConversion of hepatitis B virus relaxed circular to covalently closed circular DNA is supported in murine cells
- Open Access
- 4 April 2022
- Published by Elsevier in Cell Reports
- Vol. 39 (3) , 110714
Humanized mice reveal a macrophage-enriched gene signature defining human lung tissue protection during SARS-CoV-2 infection
- 4 April 2022
- Published by Elsevier in Cell Reports
- Vol. 39 (3) , 110714
Open AccessHumanized mice reveal a macrophage-enriched gene signature defining human lung tissue protection during SARS-CoV-2 infection
- Open Access
Macrophages govern antiviral responses in human lung tissues protected from SARS-CoV-2 infection
The majority of SARS-CoV-2 infections among healthy individuals result in asymptomatic to mild disease. However, the immunological mechanisms defining effective lung tissue protection from SARS-CoV-2 infection remain elusive. Unlike mice solely engrafted with human fetal lung xenograft (fLX), mice co-engrafted with fLX and a myeloid-enhanced human immune system (HNFL mice) are protected against SARS-CoV-2 infection, severe inflammation, and histopathology. Effective control of viral infection in HNFL mice associated with significant macrophage infiltration, and the induction of a potent macrophage-mediated interferon response. The pronounced upregulation of the USP18-ISG15 axis (a negative regulator of IFN responses), by macrophages was unique to HNFL mice and represented a prominent correlate of reduced inflammation and histopathology. Altogether, our work shed light on unique cellular and molecular correlates of lung tissue protection during SARS-CoV-2 infection, and underscores macrophage IFN responses as prime targets for developing immunotherapies against coronavirus respiratory diseases. HIGHLIGHTS Mice engrafted with human fetal lung xenografts (fLX-mice) are highly susceptible to SARS-CoV-2. Co-engraftment with a human myeloid-enriched immune system protected fLX-mice against infection. Tissue protection was defined by a potent and well-balanced antiviral response mediated by infiltrating macrophages. Protective IFN response was dominated by the upregulation of the USP18-ISG15 axis.
Open AccessMacrophages govern antiviral responses in human lung tissues protected from SARS-CoV-2 infection
The majority of SARS-CoV-2 infections among healthy individuals result in asymptomatic to mild disease. However, the immunological mechanisms defining effective lung tissue protection from SARS-CoV-2 infection remain elusive. Unlike mice solely engrafted with human fetal lung xenograft (fLX), mice co-engrafted with fLX and a myeloid-enhanced human immune system (HNFL mice) are protected against SARS-CoV-2 infection, severe inflammation, and histopathology. Effective control of viral infection in HNFL mice associated with significant macrophage infiltration, and the induction of a potent macrophage-mediated interferon response. The pronounced upregulation of the USP18-ISG15 axis (a negative regulator of IFN responses), by macrophages was unique to HNFL mice and represented a prominent correlate of reduced inflammation and histopathology. Altogether, our work shed light on unique cellular and molecular correlates of lung tissue protection during SARS-CoV-2 infection, and underscores macrophage IFN responses as prime targets for developing immunotherapies against coronavirus respiratory diseases. HIGHLIGHTS Mice engrafted with human fetal lung xenografts (fLX-mice) are highly susceptible to SARS-CoV-2. Co-engraftment with a human myeloid-enriched immune system protected fLX-mice against infection. Tissue protection was defined by a potent and well-balanced antiviral response mediated by infiltrating macrophages. Protective IFN response was dominated by the upregulation of the USP18-ISG15 axis.
- 14 December 2020
- Published by Elsevier in Antiviral Research
- Vol. 185, 104997
Isocotoin suppresses hepatitis E virus replication through inhibition of heat shock protein 90
- 14 December 2020
- Published by Elsevier in Antiviral Research
- Vol. 185, 104997
Isocotoin suppresses hepatitis E virus replication through inhibition of heat shock protein 90